United States Biotechnology & Medical Research

Zogenix Inc (ZGNX)

Track

Ticker: ZGNX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 1 Feb 2022
Value US$4,328,843.82 | Price 40.86 | Shares 56,170 (-6.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-03 2022-02-01 PlS Planned sale
MAST ERLE T
Non-Executive Director
56,170 -6.2%
40.86
US$4,328,844 		56,170 -6.2% 40.86 US$4,328,844
2022-01-21 2022-01-19 PlS Planned sale
MAST ERLE T
Non-Executive Director
92,289 +36.8%
73.80
US$1,462,673 		92,289 +36.8% 73.80 US$1,462,673
2021-11-30 2021-11-29 S Sale
3.4
TANNENBAUM RENEE P
Non-Executive Director
74,264 -40.3%
151.63
US$2,877,299 		74,264 -40.3% 151.63 US$2,877,299
2021-06-03 2021-06-01 B Purchase
Waynick Denelle J
Non-Executive Director
584 +inf%
17.07
US$9,969 		584 +inf% 17.07 US$9,969
2021-06-03 2021-06-01 B Purchase
3.4
TANNENBAUM RENEE P
Non-Executive Director
5,000 +15.2%
17.05
US$85,248 		5,000 +15.2% 17.05 US$85,248
2021-05-12 2021-05-10 B Purchase
GARNER CAM L
Non-Executive Director
15,000 +93.8%
19.03
US$285,496 		15,000 +93.8% 19.03 US$285,496
2020-11-20 2020-11-19 B Purchase
GARNER CAM L
Non-Executive Director
8,000 +100.0%
20.13
US$161,042 		8,000 +100.0% 20.13 US$161,042
2020-11-18 2020-11-17 S Sale
3.4
TANNENBAUM RENEE P
Non-Executive Director
15,000 -31.3%
20.74
US$311,066 		15,000 -31.3% 20.74 US$311,066
2020-05-13 2020-05-12 PlS Planned sale
3.7
Farfel Gail M

EVP/Chief Development Officer

Officer
2,573 -33.8%
28.21
US$72,584 		2,573 -33.8% 28.21 US$72,584
2020-05-11 2020-05-08 B Purchase
Sagrolikar Ashish M

EVP & CHIEF COMMERCIAL OFFICER

Officer
1,000 +20.4%
25.45
US$25,450 		1,000 +20.4% 25.45 US$25,450
2020-03-24 2020-03-23 B Purchase
1.0
WIGGINS MARK C
Non-Executive Director
2,500 +inf%
20.48
US$51,196 		2,500 +inf% 20.48 US$51,196
2020-03-20 2020-03-19 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
6,158 -10.0%
18.51
US$113,964 		6,158 -10.0% 18.51 US$113,964
2020-03-20 2020-03-18 B Purchase
Galer Bradley S.

EVP/Chief Medical Officer

Officer
1,000 +11.1%
19.69
US$19,685 		1,000 +11.1% 19.69 US$19,685
2020-03-18 2020-03-13 B Purchase
GARNER CAM L
Non-Executive Director
8,000 +inf%
21.83
US$174,647 		8,000 +inf% 21.83 US$174,647
2020-01-10 2020-01-08 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
5,270 -8.5%
52.20
US$275,105 		5,270 -8.5% 52.20 US$275,105
2020-01-10 2020-01-08 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
28,955 -31.8%
51.83
US$1,500,816 		28,955 -31.8% 51.83 US$1,500,816
2020-01-03 2020-01-02 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
7,550 -84.5%
52.09
US$393,277 		7,550 -84.5% 52.09 US$393,277
2020-01-03 2020-01-02 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
14,950 -62.6%
51.64
US$772,063 		14,950 -62.6% 51.64 US$772,063
2019-12-18 2019-12-16 PlS Planned sale BREITMEYER JAMES B Non-Executive Director
5,000 -80.0%
50.00
US$250,000 		5,000 -80.0% 50.00 US$250,000
2019-11-27 2019-11-25 PlS Planned sale
3.0
BREITMEYER JAMES B
5,000 -80.0%
50.00
US$250,000 		5,000 -80.0% 50.00 US$250,000
2019-11-27 2019-11-25 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
34,225 -37.7%
50.00
US$1,711,250 		34,225 -37.7% 50.00 US$1,711,250
2019-11-27 2019-11-25 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
15,000 -91.5%
48.00
US$720,000 		15,000 -91.5% 48.00 US$720,000
2019-08-23 2019-08-22 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
3,446 -41.3%
52.00
US$179,192 		3,446 -41.3% 52.00 US$179,192
2019-08-12 2019-08-09 PlS Planned sale Smith Michael P

EVP, CFO, Treasurer & Sec.

Officer
15,000 -91.5%
50.00
US$750,000 		15,000 -91.5% 50.00 US$750,000
2019-08-12 2019-08-09 PlS Planned sale WIGGINS MARK C Non-Executive Director
6,250 -100.0%
50.00
US$312,500 		6,250 -100.0% 50.00 US$312,500
2019-07-05 2019-07-03 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
19,872 -26.5%
48.16
US$957,093 		19,872 -26.5% 48.16 US$957,093
2019-07-05 2019-07-03 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
14,353 -16.1%
47.80
US$686,068 		14,353 -16.1% 47.80 US$686,068
2019-07-01 2019-06-27 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
15,000 -91.5%
46.32
US$694,800 		15,000 -91.5% 46.32 US$694,800
2019-04-02 2019-03-29 PlS Planned sale
0.6
HAWLEY ROGER
15,700 -59.8%
55.00
US$863,500 		15,700 -59.8% 55.00 US$863,500
2019-04-02 2019-03-29 PlS Planned sale
0.6
HAWLEY ROGER
5,000 -32.1%
55.00
US$275,000 		5,000 -32.1% 55.00 US$275,000
2019-03-15 2019-03-14 S Sale
0.6
HAWLEY ROGER
Non-Executive Director
38,789 -78.6%
52.93
US$2,053,261 		38,789 -78.6% 52.93 US$2,053,261
2019-03-15 2019-03-13 S Sale
0.6
HAWLEY ROGER
Non-Executive Director
21,211 -30.1%
53.10
US$1,126,215 		21,211 -30.1% 53.10 US$1,126,215
2019-03-08 2019-03-06 S Sale
3.4
TANNENBAUM RENEE P
17,503 -26.8%
50.65
US$886,474 		17,503 -26.8% 50.65 US$886,474
2019-03-05 2019-03-01 PlS Planned sale
0.6
HAWLEY ROGER
Non-Executive Director
4,300 -5.7%
50.00
US$215,000 		4,300 -5.7% 50.00 US$215,000
2019-03-05 2019-03-01 PlS Planned sale
GARNER CAM L
Non-Executive Director
15,250 -100.0%
50.00
US$762,500 		15,250 -100.0% 50.00 US$762,500
2019-02-28 2019-02-27 PlS Planned sale
GARNER CAM L
Non-Executive Director
869 -100.0%
50.00
US$43,450 		869 -100.0% 50.00 US$43,450
2019-02-28 2019-02-26 PlS Planned sale
GARNER CAM L
Non-Executive Director
4,756 -100.0%
50.00
US$237,800 		4,756 -100.0% 50.00 US$237,800
2019-02-14 2019-02-12 PlS Planned sale
GARNER CAM L
Non-Executive Director
12,405 -100.0%
46.85
US$581,147 		12,405 -100.0% 46.85 US$581,147
2019-01-11 2019-01-10 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
55,000 -51.4%
45.00
US$2,475,000 		55,000 -51.4% 45.00 US$2,475,000
2019-01-11 2019-01-10 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
35,001 -40.3%
45.00
US$1,575,045 		35,001 -40.3% 45.00 US$1,575,045
2019-01-11 2019-01-10 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
312 -0.6%
45.00
US$14,040 		312 -0.6% 45.00 US$14,040
2018-12-17 2018-12-14 S Sale HAWLEY ROGER Non-Executive Director
20,000 -22.1%
41.35
US$826,910 		20,000 -22.1% 41.35 US$826,910
2018-11-26 2018-11-26 S Sale MAST ERLE T Non-Executive Director
1,468 -32.7%
42.08
US$61,772 		1,468 -32.7% 42.08 US$61,772
2018-10-09 2018-10-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
1,961 -21.5%
43.74
US$85,766 		1,961 -21.5% 43.74 US$85,766
2018-10-09 2018-10-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
2,900 -24.2%
43.11
US$125,026 		2,900 -24.2% 43.11 US$125,026
2018-10-09 2018-10-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
2,100 -14.9%
42.92
US$90,137 		2,100 -14.9% 42.92 US$90,137
2018-09-05 2018-09-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
2,300 -24.4%
48.21
US$110,872 		2,300 -24.4% 48.21 US$110,872
2018-09-05 2018-09-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
4,700 -33.2%
47.27
US$222,170 		4,700 -33.2% 47.27 US$222,170
2018-08-14 2018-08-10 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
100,000 +2.5%
52.00
US$5,200,000 		100,000 +2.5% 52.00 US$5,200,000
2018-08-10 2018-08-08 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
1,900 -21.0%
53.16
US$100,995 		1,900 -21.0% 53.16 US$100,995
2018-08-10 2018-08-08 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
5,100 -36.1%
52.42
US$267,318 		5,100 -36.1% 52.42 US$267,318
2018-06-13 2018-06-12 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
5,118 -41.7%
45.00
US$230,310 		5,118 -41.7% 45.00 US$230,310
2018-05-17 2018-05-16 S Sale GARNER CAM L Non-Executive Director
218 -100.0%
39.90
US$8,698 		218 -100.0% 39.90 US$8,698
2018-03-14 2018-03-13 S Sale HAWLEY ROGER
27,760 -23.5%
44.65
US$1,239,437 		27,760 -23.5% 44.65 US$1,239,437
2018-03-14 2018-03-12 S Sale BOCK LOUIS C
24,716 -100.0%
44.83
US$1,108,134 		24,716 -100.0% 44.83 US$1,108,134
2018-03-14 2018-03-12 S Sale HAWLEY ROGER
7,240 -7.4%
44.97
US$325,549 		7,240 -7.4% 44.97 US$325,549
2017-12-15 2017-12-13 PP Planned purchase Galer Bradley S.

EVP/Chief Medical Officer
1,346 +50.1%
36.59
US$49,245 		1,346 +50.1% 36.59 US$49,245
2017-12-11 2017-12-11 S Sale HAWLEY ROGER
10,000 -9.9%
36.84
US$368,407 		10,000 -9.9% 36.84 US$368,407
2017-12-11 2017-12-11 S Sale HAWLEY ROGER
8,462 -8.5%
36.84
US$311,746 		8,462 -8.5% 36.84 US$311,746
2017-12-11 2017-12-11 S Sale HAWLEY ROGER
44,741 -33.1%
36.84
US$1,648,290 		44,741 -33.1% 36.84 US$1,648,290
2017-12-11 2017-12-08 S Sale HAWLEY ROGER
11,797 -11.5%
37.02
US$436,704 		11,797 -11.5% 37.02 US$436,704
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
20,000 -18.1%
36.40
US$728,000 		20,000 -18.1% 36.40 US$728,000
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
9,000 -9.0%
36.40
US$327,600 		9,000 -9.0% 36.40 US$327,600
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
12,370 -12.0%
36.40
US$450,268 		12,370 -12.0% 36.40 US$450,268
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
15,000 -14.2%
36.92
US$553,744 		15,000 -14.2% 36.92 US$553,744
2017-10-03 2017-10-03 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
300,000 +8.2%
37.50
US$11,250,000 		300,000 +8.2% 37.50 US$11,250,000
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
22,055 +0.6%
27.67
US$610,341 		22,055 +0.6% 27.67 US$610,341
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
8,920 +0.2%
40.14
US$358,081 		8,920 +0.2% 40.14 US$358,081
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
12,586 +0.3%
39.22
US$493,600 		12,586 +0.3% 39.22 US$493,600
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
8,112 +0.2%
38.56
US$312,791 		8,112 +0.2% 38.56 US$312,791
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
6,153 +0.2%
37.14
US$228,530 		6,153 +0.2% 37.14 US$228,530
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
3,800 +0.1%
36.26
US$137,805 		3,800 +0.1% 36.26 US$137,805
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
6,000 +0.2%
34.91
US$209,475 		6,000 +0.2% 34.91 US$209,475
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
8,260 +0.2%
33.86
US$279,665 		8,260 +0.2% 33.86 US$279,665
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
15,937 +0.4%
32.96
US$525,311 		15,937 +0.4% 32.96 US$525,311
Explore more

More insider trading research around Zogenix Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America